These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10960638)

  • 1. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium.
    Miller L; Patton DL; Meier A; Thwin SS; Hooton TM; Eschenbach DA
    Obstet Gynecol; 2000 Sep; 96(3):431-9. PubMed ID: 10960638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV; Castro S; Marchi NM; Marcovici M; Andrade LA; Fernandes A; Bahamondes L
    Contraception; 2014 Aug; 90(2):117-22. PubMed ID: 24613369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women.
    Yang L; Hao Y; Hu J; Kelly D; Li H; Brown S; Tasker C; Roche NE; Chang TL; Pei Z
    Emerg Microbes Infect; 2019; 8(1):197-210. PubMed ID: 30866773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.
    Mauck CK; Callahan MM; Baker J; Arbogast K; Veazey R; Stock R; Pan Z; Morrison CS; Chen-Mok M; Archer DF; Gabelnick HL
    Contraception; 1999 Jul; 60(1):15-24. PubMed ID: 10549448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.
    Roxby AC; Fredricks DN; Odem-Davis K; Ásbjörnsdóttir K; Masese L; Fiedler TL; De Rosa S; Jaoko W; Kiarie JN; Overbaugh J; McClelland RS
    J Acquir Immune Defic Syndr; 2016 Apr; 71(4):359-66. PubMed ID: 26914908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices.
    Birse KD; Romas LM; Guthrie BL; Nilsson P; Bosire R; Kiarie J; Farquhar C; Broliden K; Burgener AD
    J Infect Dis; 2017 Feb; 215(4):590-598. PubMed ID: 28011908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques.
    Butler K; Ritter J; Ellis S; Henning TR; Montague J; Zaki S; Garber D; McNicholl JM; Kersh EN
    J Med Primatol; 2015 Oct; 44(5):286-95. PubMed ID: 26238265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera.
    Bahamondes L; Trevisan M; Andrade L; Marchi NM; Castro S; Díaz J; Faúndes A
    Contraception; 2000 Jul; 62(1):23-7. PubMed ID: 11024225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells.
    Mitchell CM; McLemore L; Westerberg K; Astronomo R; Smythe K; Gardella C; Mack M; Magaret A; Patton D; Agnew K; McElrath MJ; Hladik F; Eschenbach D
    J Infect Dis; 2014 Aug; 210(4):651-5. PubMed ID: 24652495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium.
    Eschenbach DA; Patton DL; Meier A; Thwin SS; Aura J; Stapleton A; Hooton TM
    Contraception; 2000 Sep; 62(3):107-12. PubMed ID: 11124356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of tubal occlusion after transcervical polidocanol foam (PF) infusion in baboons.
    Jensen JT; Hanna C; Yao S; Bauer C; Morgan TK; Slayden OD
    Contraception; 2015 Aug; 92(2):96-102. PubMed ID: 26070857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accounting for anovulation and vaginal thinning during depot medroxyprogesterone acetate use.
    Atrio J
    J Infect Dis; 2015 Mar; 211(5):850. PubMed ID: 25217405
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques.
    Radzio J; Hanley K; Mitchell J; Ellis S; Deyounks F; Jenkins LT; Hanson D; Heneine W; García-Lerma JG
    AIDS; 2014 Jun; 28(10):1431-9. PubMed ID: 24759208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Intramuscular Depot Medroxyprogesterone Acetate Initiation on Vaginal Microbiota in the Postpartum Period.
    Whitney BM; Srinivasan S; Tapia K; Muriuki EM; Chohan BH; Wallis JM; Liu C; Guthrie BL; McClelland RS; Hoffman NG; Fredricks DN; Roxby AC
    Clin Infect Dis; 2021 Jun; 72(12):e1093-e1102. PubMed ID: 33354707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
    Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
    Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of safety in Chinese women with amenorrhea following injection of depot-medroxyprogesterone for contraception].
    Zhu M; Lei Z; Yang D
    Zhonghua Fu Chan Ke Za Zhi; 1999 Oct; 34(10):621-3. PubMed ID: 11477805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Review: Mechanisms of HIV Transmission in Depo-Provera Users: The Likely Role of Hypoestrogenism.
    Hickey M; Marino JL; Tachedjian G
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):1-7. PubMed ID: 26761267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.